Lexaria Bioscience Corp. (LEXX) › Operating IncomeLexaria Bioscience Corp. (LEXX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$1.56M2015: -$1.98M2016: -$1.28M2021: -$5.69M2022: -$6.62M2023: -$6.53M2024: -$5.75M2025: -$11.88M-$11.88M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$11.88M-106.5%2024-$5.75M+12.0%2023-$6.53M+1.3%2022-$6.62M-16.4%2021-$5.69M—2016-$1.28M+35.6%2015-$1.98M-27.2%2014-$1.56M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share